Alan Stewart Purchases 33,923 Shares of Haleon plc (LON:HLN) Stock

Haleon plc (LON:HLN - Get Free Report) insider Alan Stewart purchased 33,923 shares of the business's stock in a transaction dated Wednesday, November 6th. The stock was bought at an average price of GBX 368 ($4.79) per share, with a total value of £124,836.64 ($162,505.39).

Haleon Price Performance

Shares of Haleon stock traded up GBX 1.90 ($0.02) during trading on Friday, hitting GBX 363.60 ($4.73). 14,691,535 shares of the company were exchanged, compared to its average volume of 19,828,826. Haleon plc has a fifty-two week low of GBX 308.37 ($4.01) and a fifty-two week high of GBX 400.65 ($5.22). The company has a quick ratio of 0.93, a current ratio of 0.84 and a debt-to-equity ratio of 54.18. The firm has a 50 day moving average price of GBX 383.91 and a 200 day moving average price of GBX 354.82. The stock has a market capitalization of £32.87 billion, a price-to-earnings ratio of 3,018.88, a P/E/G ratio of 1.49 and a beta of 0.19.

Wall Street Analyst Weigh In

Separately, Berenberg Bank lifted their price objective on Haleon from GBX 410 ($5.34) to GBX 447 ($5.82) and gave the stock a "buy" rating in a report on Monday, August 5th.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.